��������

Dave Singh is professor of clinical pharmacology & respiratory medicine at the University of Manchester. His research interest is the development of new drugs for asthma and COPD, involving clinical trials, biomarker studies and basic mechanisms. He has over 250 publications.

He is a member of the GOLD Science Committee, and the chair of the ERS airway pharmacology group. He is the medical director of the Medicines Evaluation Unit, which performs both early and late phase clinical trials.